ArticleThoracic cancer2021

Impact of the generation of EGFR-TKIs administered as prior therapy on the efficacy of osimertinib in patients with non-small cell lung cancer harboring EGFR T790M mutation.

Yosuke Miyashita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.